HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 40, 41377-41383, October 1, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/40/41377    most recent M400017200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yu, L.-G. Articles by Rhodes, J. M. Search for Related Content PubMed PubMed Citation Articles by Yu, L.-G. Articles by Rhodes, J. M. Social Bookmarking                      What's this?

Protein Phosphatase 2A, a Negative Regulator of the ERK Signaling Pathway, Is Activated by Tyrosine Phosphorylation of Putative HLA Class II-associated Protein I (PHAPI)/pp32 in Response to the Antiproliferative Lectin, Jacalin^*

Lu-Gang Yu, Len C. Packman¶, Mike Weldon¶, Jane Hamlett||, and Jonathan M. Rhodes

From the Departments of Medicine and ^||Human Anatomy and Cell Biology, University of Liverpool, Liverpool, L69 3GA and the ^¶Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge, CB2 1GA, United Kingdom

Protein phosphatase 2A (PP2A) is a family of mammalian serine/threonine phosphatases that is involved in the control of many cellular functions including those mediated by extracellular signal-regulated kinase (ERK) signaling. While investigating the reversible antiproliferative effect of the dietary lectin, jacalin, which binds the Thomsen-Friedenreich antigen (galactose 1–3 N-acetylgalactosamine -), we have found that this lectin (30 µg/ml) induces rapid, transient, tyrosine phosphorylation of putative human HLA-DR-associated protein I (PHAPI, also known as the tumor suppressor pp32) in HT29 human colon cancer cells. This is accompanied by the release of PP2A from association with PHAPI, allowing increased phosphatase activity of PP2A (by 42 ± 10% at 10 min) and consequent complete dephosphorylation of the ERK kinase, MEK1/2, by 10 min and of ERK1/2 by 60 min. PHAPI knockdown by RNA interference abolished the effects of jacalin on PP2A activation and MEK inhibition. Thus phosphorylation of PHAPI/pp32 is a critical regulatory step in PP2A activation and ERK signaling.

Received for publication, January 5, 2004 , and in revised form, June 21, 2004.

^* This work was supported in part by grants from the World Cancer Research Fund (to L.-G. Y and J. M. R.), the North West Cancer Research Fund (to L.-G. Y. and J. M. R.), and by Medical Research Council Co-operative Grant GR990432 (to J. M. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 44 151-794-6820; Fax: 44-151-794-6825; E-mail: lgyu{at}liv.ac.uk.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Chen, B. Li, I. Grundke-Iqbal, and K. Iqbal I PP2A 1 Affects Tau Phosphorylation via Association with the Catalytic Subunit of Protein Phosphatase 2A J. Biol. Chem., April 18, 2008; 283(16): 10513 - 10521. [Abstract] [Full Text] [PDF]

				F. Shi, Y.-J. Chiu, Y. Cho, T. A. Bullard, M. Sokabe, and K. Fujiwara Down-regulation of ERK but not MEK phosphorylation in cultured endothelial cells by repeated changes in cyclic stretch Cardiovasc Res, March 1, 2007; 73(4): 813 - 822. [Abstract] [Full Text] [PDF]

				Z. T. Schafer, A. B. Parrish, K. M. Wright, S. S. Margolis, J. R. Marks, M. Deshmukh, and S. Kornbluth Enhanced Sensitivity to Cytochrome c-Induced Apoptosis Mediated by PHAPI in Breast Cancer Cells Cancer Res., February 15, 2006; 66(4): 2210 - 2218. [Abstract] [Full Text] [PDF]

				M. J. Van Kanegan, D. G. Adams, B. E. Wadzinski, and S. Strack Distinct Protein Phosphatase 2A Heterotrimers Modulate Growth Factor Signaling to Extracellular Signal-regulated Kinases and Akt J. Biol. Chem., October 28, 2005; 280(43): 36029 - 36036. [Abstract] [Full Text] [PDF]

				H. Tanimukai, I. Grundke-Iqbal, and K. Iqbal Up-Regulation of Inhibitors of Protein Phosphatase-2A in Alzheimer's Disease Am. J. Pathol., June 1, 2005; 166(6): 1761 - 1771. [Abstract] [Full Text] [PDF]